Conformational Transition Pathway in the Activation Process of Allosteric Glucokinase
暂无分享,去创建一个
Shaoyong Lu | Jian Zhang | Ting Shi | M. Huang | Yaxue Zhao | Yingyi Chen | Xiaobai Li | Xinyi Liu | Zhimin Huang | Min Huang
[1] K. Neet,et al. Transients and cooperativity. A slow transition model for relating transients and cooperative kinetics of enzymes. , 1972, The Journal of biological chemistry.
[2] J. Ricard,et al. Regulatory Behavior of Monomeric Enzymes , 1974 .
[3] J. Ricard,et al. Regulatory behavior of monomeric enzymes. 2. A wheat-germ hexokinase as a mnemonical enzyme. , 1974, European journal of biochemistry.
[4] J. Ricard,et al. Regulatory behavior of monomeric enzymes. 1. The mnemonical enzyme concept. , 1974, European journal of biochemistry.
[5] G. Ciccotti,et al. Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .
[6] K. Neet,et al. [8] Hysteretic enzymes , 1980 .
[7] K. Neet,et al. Hysteretic enzymes. , 1980, Methods in enzymology.
[8] W. L. Jorgensen,et al. Comparison of simple potential functions for simulating liquid water , 1983 .
[9] U. Singh,et al. A NEW FORCE FIELD FOR MOLECULAR MECHANICAL SIMULATION OF NUCLEIC ACIDS AND PROTEINS , 1984 .
[10] H. Berendsen,et al. Molecular dynamics with coupling to an external bath , 1984 .
[11] K. Neet,et al. Demonstration of a slow conformational change in liver glucokinase by fluorescence spectroscopy. , 1990, The Journal of biological chemistry.
[12] P. Tippett,et al. Observation of a kinetic slow transition in monomeric glucokinase. , 1990, Biochemistry.
[13] M. Stoffel,et al. Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus , 1992, Nature.
[14] Jürgen Schlitter,et al. Targeted Molecular Dynamics Simulation of Conformational Change-Application to the T ↔ R Transition in Insulin , 1993 .
[15] T. Darden,et al. Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .
[16] J. Beckmann,et al. Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. , 1993, The New England journal of medicine.
[17] P. Kollman,et al. A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules , 1995 .
[18] P Willett,et al. Development and validation of a genetic algorithm for flexible docking. , 1997, Journal of molecular biology.
[19] F M Matschinsky,et al. Familial hyperinsulinism caused by an activating glucokinase mutation. , 1998, The New England journal of medicine.
[20] H. Fromm,et al. Regulation of hexokinase I: crystal structure of recombinant human brain hexokinase complexed with glucose and phosphate. , 1998, Journal of molecular biology.
[21] B. Glaser,et al. Pancreatic beta-cell glucokinase: closing the gap between theoretical concepts and experimental realities. , 1998, Diabetes.
[22] D. Eisenberg,et al. Protein function in the post-genomic era , 2000, Nature.
[23] G. Henkelman,et al. Improved tangent estimate in the nudged elastic band method for finding minimum energy paths and saddle points , 2000 .
[24] G. Henkelman,et al. A climbing image nudged elastic band method for finding saddle points and minimum energy paths , 2000 .
[25] Todd J. A. Ewing,et al. DOCK 4.0: Search strategies for automated molecular docking of flexible molecule databases , 2001, J. Comput. Aided Mol. Des..
[26] Klaus Brusgaard,et al. The second activating glucokinase mutation (A456V): implications for glucose homeostasis and diabetes therapy. , 2002, Diabetes.
[27] Luhua Lai,et al. Further development and validation of empirical scoring functions for structure-based binding affinity prediction , 2002, J. Comput. Aided Mol. Des..
[28] Yufeng Shen,et al. Conformational pathways in the gating of Escherichia coli mechanosensitive channel , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[29] M. Tschöp,et al. Two birds with one stone: novel glucokinase activator stimulates glucose-induced pancreatic insulin secretion and augments hepatic glucose metabolism. , 2003, Molecular interventions.
[30] E. Schaftingen. Short-term regulation of glucokinase , 1994, Diabetologia.
[31] F. Gago,et al. Understanding the basis of resistance in the irksome Lys103Asn HIV-1 reverse transcriptase mutant through targeted molecular dynamics simulations. , 2004, Journal of the American Chemical Society.
[32] Teruyuki Nishimura,et al. Structural basis for allosteric regulation of the monomeric allosteric enzyme human glucokinase. , 2004, Structure.
[33] Giuseppe d'Annunzio,et al. Insights into the Structure and Regulation of Glucokinase from a Novel Mutation (V62M), Which Causes Maturity-onset Diabetes of the Young* , 2005, Journal of Biological Chemistry.
[34] Alan Saghatelian,et al. Erratum: Corrigendum: Assignment of protein function in the postgenomic era , 2005, Nature chemical biology.
[35] Jan Balzarini,et al. The molecular basis of resilience to the effect of the Lys103Asn mutation in non-nucleoside HIV-1 reverse transcriptase inhibitors studied by targeted molecular dynamics simulations. , 2005, Journal of the American Chemical Society.
[36] Holger Gohlke,et al. The Amber biomolecular simulation programs , 2005, J. Comput. Chem..
[37] D. Nettleton,et al. Glucose-induced conformational changes in glucokinase mediate allosteric regulation: transient kinetic analysis. , 2006, Biochemistry.
[38] J. Lindsley,et al. Whence cometh the allosterome? , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[39] Jian Zhang,et al. Conformational transition pathway in the allosteric process of human glucokinase , 2006, Proceedings of the National Academy of Sciences.
[40] M. Karplus,et al. The allosteric mechanism of yeast chorismate mutase: a dynamic analysis. , 2006, Journal of molecular biology.
[41] J. Marcinkeviciene,et al. A pre-steady state analysis of ligand binding to human glucokinase: evidence for a preexisting equilibrium. , 2007, Biochemistry.
[42] N. Goodey,et al. Allosteric regulation and catalysis emerge via a common route. , 2008, Nature chemical biology.
[43] J. Vanderkooi,et al. Sugar binding to recombinant wild-type and mutant glucokinase monitored by kinetic measurement and tryptophan fluorescence. , 2008, Biochemical Journal.
[44] P. Njølstad,et al. Catalytic activation of human glucokinase by substrate binding – residue contacts involved in the binding of D‐glucose to the super‐open form and conformational transitions , 2008, The FEBS journal.
[45] Carlos Simmerling,et al. A Partial Nudged Elastic Band Implementation for Use with Large or Explicitly Solvated Systems. , 2009, International journal of quantum chemistry.
[46] G. Ferry,et al. Binding kinetics of glucose and allosteric activators to human glucokinase reveal multiple conformational states. , 2009, Biochemistry.
[47] Shaoxian Sun,et al. Biochemical characterization of MODY2 glucokinase variants V62M and G72R reveals reduced enzymatic activities relative to wild type. , 2009, Biochemistry.
[48] Antoine Taly,et al. Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system , 2009, Nature Reviews Drug Discovery.
[49] F. Matschinsky,et al. Assessing the potential of glucokinase activators in diabetes therapy , 2009, Nature Reviews Drug Discovery.
[50] N. Mirza,et al. Developing analgesics by enhancing spinal inhibition after injury: GABAA receptor subtypes as novel targets. , 2009, Trends in pharmacological sciences.
[51] M. Larion,et al. Global fit analysis of glucose binding curves reveals a minimal model for kinetic cooperativity in human glucokinase. , 2010, Biochemistry.
[52] Geng Wu,et al. ASD: a comprehensive database of allosteric proteins and modulators , 2010, Nucleic Acids Res..
[53] Shao-Yong Lu,et al. Molecular Modeling and Molecular Dynamics Simulation Studies of the GSK3β/ATP/Substrate Complex: Understanding the Unique P+4 Primed Phosphorylation Specificity for GSK3β Substrates , 2011, J. Chem. Inf. Model..
[54] Yong-Jun Jiang,et al. Molecular modeling and molecular dynamics simulation studies on pyrrolopyrimidine-based α-helix mimetic as dual inhibitors of MDM2 and MDMX. , 2011, Journal of molecular graphics & modelling.
[55] Shao-Yong Lu,et al. Mechanism of kinase inactivation and nonbinding of FRATide to GSK3β due to K85M mutation: molecular dynamics simulation and normal mode analysis. , 2011, Biopolymers.
[56] Shao-Yong Lu,et al. Effect of double mutations K214/A–E215/Q of FRATide on GSK3β: insights from molecular dynamics simulation and normal mode analysis , 2011, Amino Acids.